您现在的位置是:知識 >>正文
【】
知識93153人已围观
简介The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a ...
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
Featured Video For You
This biosensor allows doctors to monitor a patient's vitals from anywhere
TopicsHealth
Tags:
转载:欢迎各位朋友分享到网络,但转载请说明文章出处“夫榮妻貴網”。http://www.new.maomao321.com/news/76d54799376.html
相关文章
We asked linguists if Donald Trump speaks like that on purpose
知識Donald Trump may do a good "drunk uncle at Thanksgiving" impersonation at his rallies, but amid all ...
【知識】
阅读更多內馬爾和姆巴佩為什麽掰了?(內馬爾偷瞄姆巴佩)
知識內馬爾和姆巴佩為什麽掰了 ?內馬爾偷瞄姆巴佩)_足球 ( 馬爾,兩人 )www.ty42.com 日期:2022-12-29 00:00:00| 評論(已有358291條評論) ...
【知識】
阅读更多到底去哪!C羅加盟沙特利雅得勝利?球隊主席辟謠 :不是真的(c羅何時加盟尤文)
知識到底去哪!C羅加盟沙特利雅得勝利?球隊主席辟謠 :不是真的c羅何時加盟尤文)_足球 ( 利雅得,如今 )www.ty42.com 日期:2022-12-31 00:00:00| 評論(已有358460 ...
【知識】
阅读更多